CIPLA Cipla Ltd US FDA Inspections Announcement 2023 - US FDA Inspection CIPLA LTD. - 500087 - USFDA conducted a routine cGMP inspection at InvaGen manufacturing facility in Hauppauge, New York with zero Form 483 observations..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Cipla Ltd